OrthoPediatrics (NASDAQ:KIDS) Receives Buy Rating from BTIG Research

OrthoPediatrics (NASDAQ:KIDS)‘s stock had its “buy” rating reiterated by research analysts at BTIG Research in a research note issued to investors on Monday, Benzinga reports. They presently have a $29.00 price target on the stock. BTIG Research’s price objective points to a potential upside of 29.81% from the stock’s previous close.

Other analysts also recently issued research reports about the stock. Truist Financial set a $22.00 target price on shares of OrthoPediatrics in a report on Wednesday, August 5th. Needham & Company LLC boosted their price target on shares of OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Weiss Ratings raised shares of OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 5th. TD Cowen reiterated a “buy” rating on shares of OrthoPediatrics in a research note on Monday, June 15th. Finally, Piper Sandler reissued an “overweight” rating and set a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a research report on Wednesday, August 5th. Nine analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $26.44.

OrthoPediatrics Stock Up 1.3%

Shares of NASDAQ:KIDS opened at $22.34 on Monday. The business’s 50 day moving average is $22.05 and its 200 day moving average is $19.10. OrthoPediatrics has a 12-month low of $14.42 and a 12-month high of $26.74. The stock has a market cap of $583.30 million, a price-to-earnings ratio of -13.30 and a beta of 0.99. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings results on Tuesday, August 4th. The company reported ($0.26) EPS for the quarter, beating analysts’ consensus estimates of ($0.30) by $0.04. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%.The business had revenue of $70.51 million during the quarter, compared to analyst estimates of $68.21 million. On average, sell-side analysts forecast that OrthoPediatrics will post -1.14 earnings per share for the current fiscal year.

Insider Transactions at OrthoPediatrics

In related news, Director David Pelizzon sold 302,369 shares of the business’s stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $21.01, for a total value of $6,352,772.69. Following the transaction, the director directly owned 6,201,764 shares of the company’s stock, valued at approximately $130,299,061.64. The trade was a 4.65% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Squadron Capital Llc sold 302,369 shares of the stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $21.01, for a total transaction of $6,352,772.69. Following the transaction, the insider owned 6,201,764 shares of the company’s stock, valued at approximately $130,299,061.64. The trade was a 4.65% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 2,100,000 shares of company stock worth $46,747,931 in the last ninety days. Company insiders own 32.50% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Squarepoint Ops LLC raised its holdings in shares of OrthoPediatrics by 95.0% in the 2nd quarter. Squarepoint Ops LLC now owns 195,468 shares of the company’s stock worth $3,739,000 after purchasing an additional 95,230 shares during the period. Waverly Advisors LLC grew its holdings in OrthoPediatrics by 6.7% during the second quarter. Waverly Advisors LLC now owns 12,366 shares of the company’s stock valued at $237,000 after purchasing an additional 775 shares during the period. California State Teachers Retirement System grew its holdings in OrthoPediatrics by 397.1% during the second quarter. California State Teachers Retirement System now owns 4,553 shares of the company’s stock valued at $87,000 after purchasing an additional 3,637 shares during the period. Nantahala Capital Management LLC purchased a new stake in OrthoPediatrics in the second quarter worth $4,636,002. Finally, Grandeur Peak Global Advisors LLC purchased a new stake in OrthoPediatrics in the second quarter worth $954,000. 69.05% of the stock is owned by institutional investors.

About OrthoPediatrics

OrthoPediatrics Corp. (NASDAQ: KIDS) develops, manufactures and sells orthopedic products designed specifically for children. The company focuses on addressing the distinct anatomical and clinical needs of pediatric patients, offering implants, instruments and related technologies for orthopedic surgery.

Its product portfolio includes solutions for pediatric trauma and deformity correction, scoliosis and spinal disorders, sports medicine, limb lengthening and reconstruction, and neuromuscular conditions.